Honoring the legacy of Paul A. Marks, MD, President Emeritus of Memorial Sloan Kettering Cancer Center and a distinguished scientist, the Paul Marks Prize for Cancer Research recognizes outstanding young investigators who have made significant contributions to increase the understanding of cancer or improve the treatment of the disease through basic or clinical research.
The Paul Marks Prize is awarded every other year to up to three investigators. The first recipients were named in 2001. The winners will present their work at a scientific symposium at Memorial Sloan Kettering Cancer Center and share a cash award of $150,000.
Nominations for the 2019 Paul Marks Prize for Cancer Research are now closed. Winners will be announced in the fall of 2019. For more information please contact email@example.com